Vertex touts promising launch for non-opioid pain drug Journavxnews2025-05-05T23:27:17+00:00May 5th, 2025|Endpoints News|
New opioid data may not be generalizable, FDA adcomm saysnews2025-05-05T20:55:13+00:00May 5th, 2025|Endpoints News|
FDA adcomm to review Capricor’s Duchenne cell therapynews2025-05-05T20:07:53+00:00May 5th, 2025|Endpoints News|
Bristol Myers to lay off over 500 workers in New Jerseynews2025-05-05T19:19:47+00:00May 5th, 2025|Endpoints News|
BioNTech doesn’t see ‘near-term’ impact from RFK Jr.’s vaccine policy proposalnews2025-05-05T17:25:45+00:00May 5th, 2025|Endpoints News|
White House budget proposes billions in cuts at NIH, CDCnews2025-05-02T18:17:26+00:00May 2nd, 2025|Endpoints News|
FDA withdraws compliance deadlines for makers of bone allograftsnews2025-05-02T15:43:57+00:00May 2nd, 2025|Endpoints News|
Cytokinetics’ stock drops after heart drug PDUFA pushed back due to lack of REMSnews2025-05-02T10:20:53+00:00May 2nd, 2025|Endpoints News|
HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policynews2025-05-01T20:01:49+00:00May 1st, 2025|Endpoints News|
Amgen’s obesity drug MariTide starts Phase 3, new program in Phase 1news2025-05-01T20:01:41+00:00May 1st, 2025|Endpoints News|
